Streetbeat News

Partnerships

PXMD

PaxMedica, Inc. (NASDAQ:PXMD) has engaged Bourne Partners to explore potential monetization of a Priority Review Voucher (PRV) prior to filing the NDA for PAX-101 for the treatment of African Sleeping Sickness. PaxMedica anticipates qualifying for the PRV program as their treatment targets a rare, fatal tropical disease. However, PaxMedica has not been granted a PRV, and there is no guarantee that one will be awarded. PaxMedica also reports that the amount outstanding under PaxMedica's convertible note with Lind Global Partners II, LP has decreased from $3.68 million to $2.27 million.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 12:57 pm

EMKR

KTOS

EMCORE Corporation (EMKR) has announced a long-term supply partnership with Kratos Unmanned Aerial Systems for its SDI500 Quartz MEMS Inertial Measurement Units (IMU). The IMUs will be used in multiple advanced unmanned aerial defense programs, including the XQ-58 Valkyrie, BQM-167A Air Force Subscale Aerial Target (AFSAT), BQM-177A Sub-Sonic Aerial Target (SSAT), and MQM-178 Firejet aerial target drone. The SDI500 was ranked 1st in overall accuracy in a U.S. Military-commissioned IMU trade study.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 12:56 pm

AFRM

AMZN

Amazon is set to introduce a 'Buy Now, Pay Later' option for small business owners, in partnership with Affirm. This move is expected to provide flexible payment options for small businesses, potentially boosting their sales.

Portfolio Pulse from Charles Gross

November 02, 2023 | 12:56 pm

AREC

American Resources Corporation (NASDAQ:AREC) subsidiary, ReElement Technologies, has achieved an ultra-high purity of 99.96% battery-grade lithium carbonate from its patented multi-modal chromatography technology developed in partnership with Purdue University. The technology is scalable and flexible, allowing efficient separation, purification, refining, and recycling of critical elements for the electrified economy. The company expects price volatility around planned battery plants within the U.S. market in the short term.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 12:51 pm

JAGX

Jaguar Health, Inc. (NASDAQ:JAGX) has entered into a revenue sharing license and commercialization agreement with Quadri Pharmaceuticals Store LLC. The agreement grants Quadri Pharma exclusive rights to promote, commercialize, and distribute a powder formulation of crofelemer for rare intestinal failure diseases in multiple Middle East countries, following regulatory approval. Quadri Pharma will cover 50% of the development costs for the specified rare disease indications for three years.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 12:50 pm

APO

CNQ

MSFT

TSLA

On CNBC's 'Halftime Report Final Trades', several stocks were discussed. Richard Saperstein of Treasury Partners mentioned Canadian Natural Resources Limited (CNQ) which recently reported Q3 earnings, missing estimates. Stephen Weiss of Short Hills Capital Partners is short on Tesla (TSLA), despite CEO Elon Musk's optimism about the company's deliveries. Bryn Talkington of Requisite Capital Management named Microsoft (MSFT) as her final trade, highlighting its partnership with Siemens. Joseph Terranova of Virtus Investment Partners picked Apollo Global Management (APO) and Trane Technologies (TT).

Portfolio Pulse from Lisa Levin

November 02, 2023 | 12:41 pm

GOOGL

MSFT

QCOM

SSNLF

Samsung Electronics Co Ltd. plans to introduce generative AI technology to its Galaxy smartphones, starting with the Galaxy S24. The technology will allow AI-related tasks to be performed directly on the smartphone without an internet connection. The Galaxy S24 might use Qualcomm Inc.'s Snapdragon 8 Gen 3 chipset, which has AI-specific features. It's unclear if Samsung will use Microsoft Corp.-backed OpenAI's ChatGPT or a different solution.

Portfolio Pulse from Rounak Jain

November 02, 2023 | 12:33 pm

AUID

International fintech provider Bieases has chosen authID Inc. (NASDAQ:AUID) to secure its digital wallet. The partnership will see the launch of authID's biometric authentication platform to prevent identity fraud and account takeover. Bieases operates in the US, UK, and EU, offering financial services and payments through its digital wallet. The authID platform will provide strong identity verification and document authentication for online onboarding, binding the verified identity to the Bieases digital wallet.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 12:29 pm

BRAG

MGM

Bragg Gaming Group has launched its new content and Remote Game Server (RGS) technology with BetMGM in New Jersey. The content rollout is powered by Bragg's new RGS technology with BetMGM. Bragg also provides iGaming content for BetMGM players in Michigan and Pennsylvania. The interactive casino market in New Jersey is expected to generate $1.8 billion in Gross Win in 2023.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 12:29 pm

TNXP

Tonix Pharmaceuticals' vaccine candidate, TNX-1800, has been selected by the National Institute of Allergy and Infectious Diseases (NIAID) for inclusion in early phase clinical trials. The trials are part of the Project NextGen initiative, aimed at developing the next generation of vaccines and therapeutics for COVID-19. The Phase 1 clinical trial of TNX-1800 is expected to start in the second half of 2024, with NIAID covering the full cost of the trial. Tonix will supply the vaccine candidate.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 12:26 pm